The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clostridium Vaccine (Animal Health) Market Research Report 2024
Synopsis
Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg.
The global Clostridium Vaccine (Animal Health) market was valued at US$ 417.7 million in 2023 and is anticipated to reach US$ 521.8 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 187%.
This report aims to provide a comprehensive presentation of the global market for Clostridium Vaccine (Animal Health), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clostridium Vaccine (Animal Health).
Report Scope
The Clostridium Vaccine (Animal Health) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clostridium Vaccine (Animal Health) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clostridium Vaccine (Animal Health) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Bimeda
Boehringer Ingelheim
Ceva
Elanco
Merck Animal Health
Sanofi S.A.
Virbac
Zoetis
Segment by Type
Bovine
Ovine
Caprine
Swine
Poultry
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clostridium Vaccine (Animal Health) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clostridium Vaccine (Animal Health) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg.
The global Clostridium Vaccine (Animal Health) market was valued at US$ 417.7 million in 2023 and is anticipated to reach US$ 521.8 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 187%.
This report aims to provide a comprehensive presentation of the global market for Clostridium Vaccine (Animal Health), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clostridium Vaccine (Animal Health).
Report Scope
The Clostridium Vaccine (Animal Health) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clostridium Vaccine (Animal Health) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clostridium Vaccine (Animal Health) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Bimeda
Boehringer Ingelheim
Ceva
Elanco
Merck Animal Health
Sanofi S.A.
Virbac
Zoetis
Segment by Type
Bovine
Ovine
Caprine
Swine
Poultry
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clostridium Vaccine (Animal Health) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clostridium Vaccine (Animal Health) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Clostridium Vaccine (Animal Health) Market Overview
1.1 Product Overview and Scope of Clostridium Vaccine (Animal Health)
1.2 Clostridium Vaccine (Animal Health) Segment by Type
1.2.1 Global Clostridium Vaccine (Animal Health) Market Value Comparison by Type (2024-2030)
1.2.2 Bovine
1.2.3 Ovine
1.2.4 Caprine
1.2.5 Swine
1.2.6 Poultry
1.3 Clostridium Vaccine (Animal Health) Segment by Application
1.3.1 Global Clostridium Vaccine (Animal Health) Market Value by Application: (2024-2030)
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.4 Global Clostridium Vaccine (Animal Health) Market Size Estimates and Forecasts
1.4.1 Global Clostridium Vaccine (Animal Health) Revenue 2019-2030
1.4.2 Global Clostridium Vaccine (Animal Health) Sales 2019-2030
1.4.3 Global Clostridium Vaccine (Animal Health) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Clostridium Vaccine (Animal Health) Market Competition by Manufacturers
2.1 Global Clostridium Vaccine (Animal Health) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Clostridium Vaccine (Animal Health) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Clostridium Vaccine (Animal Health) Average Price by Manufacturers (2019-2024)
2.4 Global Clostridium Vaccine (Animal Health) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Clostridium Vaccine (Animal Health), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clostridium Vaccine (Animal Health), Product Type & Application
2.7 Clostridium Vaccine (Animal Health) Market Competitive Situation and Trends
2.7.1 Clostridium Vaccine (Animal Health) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Clostridium Vaccine (Animal Health) Players Market Share by Revenue
2.7.3 Global Clostridium Vaccine (Animal Health) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Clostridium Vaccine (Animal Health) Retrospective Market Scenario by Region
3.1 Global Clostridium Vaccine (Animal Health) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Clostridium Vaccine (Animal Health) Global Clostridium Vaccine (Animal Health) Sales by Region: 2019-2030
3.2.1 Global Clostridium Vaccine (Animal Health) Sales by Region: 2019-2024
3.2.2 Global Clostridium Vaccine (Animal Health) Sales by Region: 2025-2030
3.3 Global Clostridium Vaccine (Animal Health) Global Clostridium Vaccine (Animal Health) Revenue by Region: 2019-2030
3.3.1 Global Clostridium Vaccine (Animal Health) Revenue by Region: 2019-2024
3.3.2 Global Clostridium Vaccine (Animal Health) Revenue by Region: 2025-2030
3.4 North America Clostridium Vaccine (Animal Health) Market Facts & Figures by Country
3.4.1 North America Clostridium Vaccine (Animal Health) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Clostridium Vaccine (Animal Health) Sales by Country (2019-2030)
3.4.3 North America Clostridium Vaccine (Animal Health) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Clostridium Vaccine (Animal Health) Market Facts & Figures by Country
3.5.1 Europe Clostridium Vaccine (Animal Health) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Clostridium Vaccine (Animal Health) Sales by Country (2019-2030)
3.5.3 Europe Clostridium Vaccine (Animal Health) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clostridium Vaccine (Animal Health) Market Facts & Figures by Country
3.6.1 Asia Pacific Clostridium Vaccine (Animal Health) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Clostridium Vaccine (Animal Health) Sales by Country (2019-2030)
3.6.3 Asia Pacific Clostridium Vaccine (Animal Health) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Clostridium Vaccine (Animal Health) Market Facts & Figures by Country
3.7.1 Latin America Clostridium Vaccine (Animal Health) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Clostridium Vaccine (Animal Health) Sales by Country (2019-2030)
3.7.3 Latin America Clostridium Vaccine (Animal Health) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Clostridium Vaccine (Animal Health) Market Facts & Figures by Country
3.8.1 Middle East and Africa Clostridium Vaccine (Animal Health) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Clostridium Vaccine (Animal Health) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Clostridium Vaccine (Animal Health) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Clostridium Vaccine (Animal Health) Sales by Type (2019-2030)
4.1.1 Global Clostridium Vaccine (Animal Health) Sales by Type (2019-2024)
4.1.2 Global Clostridium Vaccine (Animal Health) Sales by Type (2025-2030)
4.1.3 Global Clostridium Vaccine (Animal Health) Sales Market Share by Type (2019-2030)
4.2 Global Clostridium Vaccine (Animal Health) Revenue by Type (2019-2030)
4.2.1 Global Clostridium Vaccine (Animal Health) Revenue by Type (2019-2024)
4.2.2 Global Clostridium Vaccine (Animal Health) Revenue by Type (2025-2030)
4.2.3 Global Clostridium Vaccine (Animal Health) Revenue Market Share by Type (2019-2030)
4.3 Global Clostridium Vaccine (Animal Health) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Clostridium Vaccine (Animal Health) Sales by Application (2019-2030)
5.1.1 Global Clostridium Vaccine (Animal Health) Sales by Application (2019-2024)
5.1.2 Global Clostridium Vaccine (Animal Health) Sales by Application (2025-2030)
5.1.3 Global Clostridium Vaccine (Animal Health) Sales Market Share by Application (2019-2030)
5.2 Global Clostridium Vaccine (Animal Health) Revenue by Application (2019-2030)
5.2.1 Global Clostridium Vaccine (Animal Health) Revenue by Application (2019-2024)
5.2.2 Global Clostridium Vaccine (Animal Health) Revenue by Application (2025-2030)
5.2.3 Global Clostridium Vaccine (Animal Health) Revenue Market Share by Application (2019-2030)
5.3 Global Clostridium Vaccine (Animal Health) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Clostridium Vaccine (Animal Health) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Bimeda
6.2.1 Bimeda Corporation Information
6.2.2 Bimeda Description and Business Overview
6.2.3 Bimeda Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bimeda Clostridium Vaccine (Animal Health) Product Portfolio
6.2.5 Bimeda Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Clostridium Vaccine (Animal Health) Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Clostridium Vaccine (Animal Health) Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Clostridium Vaccine (Animal Health) Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Animal Health Clostridium Vaccine (Animal Health) Product Portfolio
6.6.5 Merck Animal Health Recent Developments/Updates
6.7 Sanofi S.A.
6.6.1 Sanofi S.A. Corporation Information
6.6.2 Sanofi S.A. Description and Business Overview
6.6.3 Sanofi S.A. Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi S.A. Clostridium Vaccine (Animal Health) Product Portfolio
6.7.5 Sanofi S.A. Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Corporation Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Virbac Clostridium Vaccine (Animal Health) Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Corporation Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Clostridium Vaccine (Animal Health) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zoetis Clostridium Vaccine (Animal Health) Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clostridium Vaccine (Animal Health) Industry Chain Analysis
7.2 Clostridium Vaccine (Animal Health) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clostridium Vaccine (Animal Health) Production Mode & Process
7.4 Clostridium Vaccine (Animal Health) Sales and Marketing
7.4.1 Clostridium Vaccine (Animal Health) Sales Channels
7.4.2 Clostridium Vaccine (Animal Health) Distributors
7.5 Clostridium Vaccine (Animal Health) Customers
8 Clostridium Vaccine (Animal Health) Market Dynamics
8.1 Clostridium Vaccine (Animal Health) Industry Trends
8.2 Clostridium Vaccine (Animal Health) Market Drivers
8.3 Clostridium Vaccine (Animal Health) Market Challenges
8.4 Clostridium Vaccine (Animal Health) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
